Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street


Income investors can be growth investors, too. Granted, it's not always easy to find stocks that pay generous dividends and offer solid prospects of share price appreciation. However, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49% over the next 12 months, according to Wall Street.

(NYSE: PFE) stock has been on a downward trajectory for nearly two and a half years. Blame it mainly on declining demand for the company's COVID-19 vaccine and oral antiviral drug Paxlovid. However, Pfizer also faces the looming loss of exclusivity for multiple products.

Despite this bad news, analysts remain perhaps surprisingly bullish about Pfizer. The average analysts' 12-month price target reflects an upside potential of around 22%. Not everyone on Wall Street is enamored with Pfizer. One analyst surveyed by LSEG in April recommended selling the stock. But over half of the analysts polled rated Pfizer as a buy or a strong buy.

Continue reading


Source Fool.com

Pfizer Inc. Stock

€26.20
-0.660%
Pfizer Inc. shows a slight decrease today, losing -€0.175 (-0.660%) compared to yesterday.
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 52.67% compared to the current price of 26.2 € for Pfizer Inc..
Like: 0
BEP
Share

Comments